IXHL

Incannex Healthcare (IXHL)

Incannex Healthcare Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IXHL

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/30	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/05/30	20:30	GlobeNewswire Inc.	Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/05/07	20:30	GlobeNewswire Inc.	Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/04/16	21:00	GlobeNewswire Inc.	Incannex Healthcare Inc. Quarterly Update, Q1 2024	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/02/28	21:30	GlobeNewswire Inc.	Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/02/16	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/02/16	21:30	GlobeNewswire Inc.	Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/02/14	20:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/02/01	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/02/01	21:30	GlobeNewswire Inc.	Clarion Clinics Open for Psychedelic-Assisted Treatments	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/01/25	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/01/25	06:05	GlobeNewswire Inc.	Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/01/18	23:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/01/18	22:22	GlobeNewswire Inc.	Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/01/17	21:30	GlobeNewswire Inc.	Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea	NASDAQ:IXHL	Incannex Healthcare Ltd
2024/01/17	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/22	20:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/22	10:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/22	10:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/22	10:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/22	10:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/22	06:05	GlobeNewswire Inc.	Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/21	07:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/12/06	21:30	GlobeNewswire Inc.	Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/11/30	03:40	GlobeNewswire Inc.	Incannex Healthcare Announces Completion of its Redomiciliation to the United States	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/11/16	23:38	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/11/16	22:30	GlobeNewswire Inc.	Federal Court of Australia Approves Incannex’s Re-Domiciliation and Lodgement of Court Orders With ASIC	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/11/08	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/10/26	19:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IXHL	Incannex Healthcare Ltd
2023/09/08	20:30	GlobeNewswire Inc.	Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023	NASDAQ:IXHL	Incannex Healthcare Ltd